LAVA Therapeutics NV (LVTX) Q4 2024 Earnings

10DecConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.51
-0.34
-0.17
0

Details

Expected EPS
-0.33
Actual EPS
-0.46
Surprise EPS
-0.13
Surprise Percent
+39.39%

Description

LAVA Therapeutics NV (LVTX) has reported earnings of -0.46 per share for Q4 2024.

0 Comments

Share your thoughts